Clinical Trial Update: Study to Observe Safety of Xarelto in VTE Prophlylaxis After Elective TKR (Total Knee Replacement) or THR (Total Hip Replacement)

View source ↗

Summary

The Bayer-sponsored trial evaluating rivaroxaban for venous thromboembolism prophylaxis after elective total knee replacement or total hip replacement has been …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Thromboembolism

Drugs mentioned

• Xarelto (rivaroxaban)

Snippet

Sponsor: Bayer | Conditions: Prophylaxis, Thromboembolism, Venous, Total Knee Replacement | Status: WITHDRAWN